Eight Medical Appoints Jesus Esquivel, M.D. to its Medical Advisory Board

Share Article

Eight Medical Corp., developers of the most advanced intraperitoneal hyperthermia device for cancer treatment, announced today the appointment of Jesus Esquivel, M.D. to the company’s Medical Advisory Board.

Eight Medical Corp., developers of the most advanced intraperitoneal hyperthermia device for cancer treatment, announced today the appointment of Jesus Esquivel, M.D. to the company’s Medical Advisory Board. Dr. Esquivel brings more than 20 years of clinical experience to his role, including extensive expertise in the field of peritoneal surface malignancies, tumors that originated in the appendix, colon, rectum, stomach, or ovaries and spread to the peritoneal surfaces of the abdominal cavity.

Following his General Surgery training program, Dr. Esquivel completed a two year fellowship in Gastrointestinal Surgical Oncology and Cytoreductive Surgery with Hyperthermic Intraperitoneal Perfusion at the Washington Cancer Institute in Washington, D.C. After completing this fellowship in 1999, Dr. Esquivel remained at the Washington Cancer Institute until December 2004 when he moved to St. Agnes Hospital in Baltimore, Md. to become the Director of the Peritoneal Surface Malignancy Program.

Dr. Esquivel's practice at St. Agnes Hospital is focused exclusively on Peritoneal Surface Malignancies of the appendix, colon, ovary, stomach and peritoneal mesothelioma. Dr. Esquivel has helped author more than 50 scientific articles in peer-reviewed publications on advanced cancer treatment, has contributed multiple book chapters on peritoneal malignancies and the use of hyperthermia in cancer care, and has lectured extensively on the subject both nationally and internationally. Dr. Esquivel is currently the President of the American Society of Peritoneal Surface Malignancies.

“Dr. Esquivel is one of the proven international leaders in the treatment of various cancers using hyperthermic delivery and therefore a vital member of our Medical Advisory Board,” said Albert H. Huttenga, President and CEO of Eight Medical. “Dr. Esquivel’s firsthand experience and in-depth knowledge will be invaluable to the evolution of our company and the continued advancement of our technology, as we work together to improve patient outcomes.”
“It’s an honor to be a part of Eight Medical’s Medical Advisory Board and for the opportunity to work closely with other experts in the field,” said Jesus Esquivel, M.D. “The Eight Medical team is extremely knowledgeable in the field of intraperitoneal hyperthermia and their level of commitment to advancing the science, from technology to research, and to fostering collaboration amongst providers is unmatched in the industry.”

About Eight Medical

Eight Medical Corp., located in Bloomington, Ind., is the principal operating entity in the Eight Medical organization- an international group of affiliated business involved in the manufacture and sale of high end medical technology. The company’s leading technology, the Recirculator 8.0, is an FDA-cleared and CE-approved medical device designed and manufactured for Intraperitoneal Hyperthermia (IPH) and Intrathoracic Hyperthermia (ITH), and used for the treatment of certain types of cancer. Surgical oncologists in almost all major cancer centers use this new technology to simply, efficiently and reliably direct a heated sterile solution through the lower abdomen or thoracic cavity, in conjunction with cytoreductive surgery for the treatment of advanced cancers.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Albert Huttenga
Eight Medical
812-822-0404
Email >

Media